Donghua H. He
Qingchun Road 79
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Efficacy and Safety of Low-Frequency Daratumumab Regimen in Systemic Light-Chain Amyloidosis.
Journal: Cancer medicine
Published: December 11, 2025
MRD contamination in peripheral blood autologous stem cell grafts: implications for relapse and prognosis in multiple myeloma.
Journal: Leukemia & lymphoma
Published: December 04, 2025
Phase I clinical study of humanized BCMA-single-domain antibodies targeting CAR-T in patients with relapsed or refractory multiple myeloma.
Journal: Cancer biology & medicine
Published: October 21, 2025
Impact of Frontline Treatment Strategies on Outcomes in Patients With Acute Myeloid Leukemia, Myelodysplasia-Related.
Journal: Cancer reports (Hoboken, N.J.)
Published: August 19, 2025
Dialysis dependence is associated with poor prognosis in multiple myeloma: a multicenter retrospective cohort study.
Journal: Therapeutic advances in medical oncology
Published: April 07, 2025
Impact of KIT mutation on efficacy of venetoclax and hypomethylating agents in newly diagnosed acute myeloid leukemia.
Journal: European journal of medical research
Published: March 02, 2025
Selective efficacy of venetoclax in unfit patients with acute myeloid leukemia with myelodysplasia-related gene mutations under low-intensity therapy.
Journal: Annals of hematology
Published: January 15, 2025
Macrophages promote aberrant DNA repair in multiple myeloma via the CXCL5/8-CXCR2 axis.
Journal: Haematologica
Published: January 07, 2025
N6-methyladenosine-mediated upregulation of H19 promotes resistance to bortezomib by modulating the miR-184/CARM1 axis in multiple myeloma.
Journal: Clinical and experimental medicine
Published: November 25, 2024
When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study.
Journal: Hematology (Amsterdam, Netherlands)
Published: October 07, 2024
The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patients.
Journal: Cancer biology & therapy
Published: September 19, 2024
Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia.
Journal: Targeted oncology
Published: January 31, 2024
Last Updated: 09/26/2026